CG Oncology (CGON) EPS (Basic) (2023 - 2026)

CG Oncology (CGON) reported EPS (Basic) of -$0.71 for Q1 2026, down 57.78% on a YoY basis from -$1.68 in Q1 2025, and down 39.22% quarter-over-quarter from -$0.51 in Q4 2025.

CG Oncology (CGON) EPS (Basic) (2023 - 2026) Analysis & Trends

CG Oncology has reported EPS (Basic) for 4 years, with the latest figure at -$0.71 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) fell 57.78% year-over-year to -$0.71; the trailing twelve-month figure through Mar 2026 stood at -$2.33 (down 54.3% YoY), and the FY2025 full-year result was -$2.08, down 47.52% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.71, down from -$0.51 in the prior quarter.
  • The five-year high for EPS (Basic) was -$0.28 in Q2 2024, with the low at -$4.47 in Q4 2023.
  • Historically, EPS (Basic) has averaged -$1.52 across 4 years, with a median of -$0.54 in 2025.
  • Annual changes were most pronounced in 2024 — EPS (Basic) surged 92.88% — and 2025, when it plunged 92.86%.
  • CG Oncology's EPS (Basic) stood at -$4.47 in 2023, then jumped by 89.26% to -$0.48 in 2024, then dropped by 6.25% to -$0.51 in 2025, then plunged by 39.22% to -$0.71 in 2026.
  • The last three EPS (Basic) figures came in at -$0.71 (Q1 2026), -$0.51 (Q4 2025), and -$0.57 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -0.68
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 3.06
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 0.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 0.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 0.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 4.06
9 Abivax 91.96 Bn 91.96 Bn - -0.06
10 CG Oncology 5.16 Bn 5.16 Bn -1.88 Mn -0.71

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.71
Dec 31, 2025 -0.51
Sep 30, 2025 -0.57
Jun 30, 2025 -0.54
Mar 31, 2025 -0.45
Dec 31, 2024 -0.48
Sep 30, 2024 -0.30
Jun 30, 2024 -0.28
Mar 31, 2024 -0.36
Dec 31, 2023 -4.47
Sep 30, 2023 -4.00
Jun 30, 2023 -3.93
Mar 31, 2023 -3.22